Closing Bell: Fennec Pharmaceuticals Inc down on Thursday (FRX)

In today's trading, shares of Fennec Pharmaceuticals Inc opened at $8.89 and closed at $8.64. Intraday prices ranged from a low of $8.50 to a high of $8.89.

Shares decreased -2.81 percent from the previous day's close of $8.89.

Today across North America, the TSX Composite closed -1.68% at 22723.21, the S&P 500 closed 1.58% at 5522.30, the Dow Jones Industrial Average closed 0.24% at 40842.79 and the Nasdaq Composite closed 2.64% at 17599.40.

Fennec Pharmaceuticals Inc traded under FRX on the Toronto Stock Exchange (TSX).

Trading volume was 700 on 7 total trades. On average, Fennec Pharmaceuticals Inc has traded 547 shares in the last five days and 1,720 year-to-date.

The TSX overall saw 907 price advancers against 4,327 declines and 72 unchanged.

During the prior 52 weeks, FRX.TO has traded as high as $15.43 (December 28,2023) and low as $7.80 (July 05,2024). Moreover, in the last 52 weeks, Fennec Pharmaceuticals Inc's shares have shrunken -23.34%, while they have shrunken -43.01% since the start of 2024.

Following today's trading, Fennec Pharmaceuticals Inc has a market capitalization of $242.89 million on a float of 27,322 shares outstanding. Its annual EPS is $0.04.

Fennec Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Research Triangle Park, USA.

Currently, Fennec Pharmaceuticals Inc has an average recommendation of "Strong Buy" based on 6.00 analysts according to Zacks. From those 6 analysts, 6 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..